Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Lacosamide-13C, D3 Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Certified reference material

Manufacturer:  MilliporeSigma Supelco L0321ML

Catalog No. 01-001-543


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™.
Specifications

Specifications

75-05-8
2°C (35.6°F) - closed cup
13CC12D3H15N2O3
1 mL
UN 1648 3 / PGII
1.0 mg/mL in acetonitrile
254.30
Ampule
-20°C
Safety and Handling

Safety and Handling

H332-H319

H312

SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation